4 Reasons to Pursue Biostatistician Jobs

The pharmaceuticals industry has been revolutionised over the last decade due to advances in technology and globalisation – and with it have come changes in clinical research. However, the US has maintained its majority share of the market and oncology remains the most valuable branch of therapy.

As for the public’s involvement, they’re becoming increasingly aware of the drugs they’re being prescribed which has pushed pharma companies to develop a more personalised level of treatment in the form of precision medicine. These factors are the key driving forces behind the growth of the industry over the last decade and we only expect this to continue, which means the future is bright for clinical research professionals.

Here’s an overview of an exciting decade in pharmaceuticals.

Digital is revolutionising pharmaceuticals

Like every industry, pharmaceuticals has been transformed by digital technologies. Predictive analytics, big data analytics and AI-based tools have given companies the tools they need to redesign their business processes. Using this new information to create a revived business model means that companies can produce drugs faster than ever before while artificial intelligence has enabled us to improve a patient’s responsiveness to drugs.

The industry hasn’t missed out on tapping into the app market – according to Deloitte, from 2013 to 2016 pharma companies tripled the number of apps they developed. This is one example of how we’ve seen pharma shift towards being more patient-centric as these apps allow the public the be more in control of their health and engage better with companies on patient platforms.

Further to this, the current pandemic has transformed the industry at all levels, leaving many questions, such as, 'Could remote decentralised clinical trials be the future?'

Globalisation of pharma

As we entered the 2010s, we witnessed products for drugs being sourced and manufactured internationally, then sold on a global market platform – this globalisation is a first for the pharmaceuticals industry. Before this decade there were several R&D hubs but from 2010 onwards this shifted towards a global outsourcing of research capabilities and the mass manufacturing of drugs for both the developed and developing markets. This globalisation means that the CIVET group - Cambodia, Indonesia, Vietnam, Egypt and Turkey - now have access to drugs, which is one major contributor to the growth of the pharmaceutical industry.

A decade of growth for pharma

It was announced in 2018 that the global pharmaceuticals market had cashed $1.2 trillion in revenue, which is a soaring 35% increase in just 10 years. America continues to have the biggest impact on this figure for various reasons, including lower taxes on drugs, a drop in prices and more relaxed regulatory barriers for new drugs.

Globally, we’re experiencing an ageing population who are presenting more complex health conditions which need medication. In 2010 China was the third largest pharmaceutical market and since then they’ve climbed up to second place, only behind the US, which remains a leader in clinical research. A key reason for this rise in the ranks is that in 2019, between August and November, their drug reimbursement list added 218 new medicines.

As the list continues to grow we expect the Chinese pharmaceuticals market to continue booming and helping the overall marketing grow from strength to strength.

Prescription medicines

In 2019 spending on prescription drugs hit US$500 billion, reflecting a two-fold increase in the last 10 years. Yet, according to Market Watch, 2019 also marked the first time in 47 years the price of prescription medicine has dropped, falling 6% lower than the price in 2010. The makeup of these drugs has transformed over the decade too, starting as small molecule or biologics and switching to in silico in 2010. This was a step towards developing treatments that were personalised for each patient and enabled the introduction of cell-based and gene-based therapies in 2011 and 2012 respectively.

The advent of precision medicine

Precision medicine considers a person’s genes, environment and lifestyle to predict which treatment will be most effective. The defining feature of this practice of medicine is the focus on genomic data to design the specific treatment paths - in other words, the study of how a person will respond to a drug based on their genetic makeup.

The advent of precision medicine has allowed the development of effective and safe medication that is tailored to the individual, thereby helping to improve the health of people who are not responding to standardised options. But pharma companies are only just scratching the surface of precision medicine as it’s expected that by 2025 the market will be worth US$85.5 billion.

Join us for another exciting decade in pharmaceuticals

If you want to work with the world’s top pharma, biotechnology and medical device companies, bring your career to ICON. We’re a leading clinical research organisation and are always looking for talented and driven people to help us become the partner of choice in drug development, particularly those who are clinical research associates.

View our clinical research jobs or browse all job categories to narrow your search.

Related Content

List #1

Related jobs at ICON

ECOA Project Manager

Salary

Location

Europe

Department

Regulatory, Drug Safety/ Quality Assurance & Other roles

Location

Any EMEA Location

Remote Working

Remote

Business Area

ICON Strategic Solutions

Job Categories

Other

Job Type

Permanent

Description

ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us

Reference

2024-109940

Expiry date

01/01/0001

Author

Rajvir Samra

Author

Rajvir Samra

Read more Shortlist Save this role

Senior Auditor, Quality Assurance

Salary

Location

Bulgaria, Sofia

Department

Full Service - Quality Assurance

Location

Sofia

Warsaw

Remote Working

Hybrid: Office/Remote

Business Area

ICON Full Service & Corporate Support

Job Categories

Quality Assurance

Job Type

Permanent

Description

Role : Auditor, Quality Assurance This role will be based in one of the countries listed GCP experience is mandatory for this role At ICON, it’s our people that set us apart.As a global provider of dr

Reference

JR118489

Expiry date

01/01/0001

Author

Mina Ghedjati

Author

Mina Ghedjati

Read more Shortlist Save this role

Senior Statistical Programmer I

Salary

Location

UK, London (PRA)

Department

Full Service - Development & Commercialisation Solutions

Location

Dublin

Warsaw

London

Remote Working

Hybrid: Office/Remote

Business Area

ICON Full Service & Corporate Support

Job Categories

Clinical Programming

Job Type

Permanent

Description

At ICON, it’s our people that set us apart. Our diverse teams enable us to become a better partner to our customers and help us to fulfil our mission to advance and improve patients’ lives. Our ‘Own I

Reference

JR114661

Expiry date

01/01/0001

Author

Sophia Cairns

Author

Sophia Cairns

Read more Shortlist Save this role

Senior Clinical Trial Transparency Associate

Salary

Location

Germany, Europe, United Kingdom, Switzerland

Department

Medical Affiars & Medical Writing Roles

Location

Any EMEA Location

Germany

Switzerland

Remote Working

Remote

Business Area

ICON Strategic Solutions

Job Categories

Medical Writing

Job Type

Permanent

Description

Senior Clinical Trial Transparency Associate is in charge of preparing scientific content to be posted on intranet websites (Health Authority, Company) based on source documents, according to defined

Reference

2024-109700

Expiry date

01/01/0001

Author

Natalia Roth

Author

Natalia Roth

Read more Shortlist Save this role

View all

List #1

A better career. A better world. A better you.

Our people are our greatest strength, are the core of our culture and the driving force behind our success. Throughout all levels of the company, our people have a drive to succeed and a passion that ensures what we do, we do well. We help you build exciting and rewarding careers, deliver results to help bring life-changing medicine and devices to market and maintain ICON’s success as an industry leader.
See all locations

Read more

Full Service

ICON Strategic Solutions

Government and public health services

Global Business Services

Overview of Service Lines

Why icon? full service mean for you?

graduate What does full service mean for you?

How has the pharmaceuticals industry changed in the last decade?

Digital is revolutionising pharmaceuticals

Globalisation of pharma

A decade of growth for pharma

Prescription medicines

The advent of precision medicine

Join us for another exciting decade in pharmaceuticals

Related Content

ICON & You
The potential of together.

A better career. A better world. A better you.

Government and public health services

Why icon? full service mean for you?

How has the pharmaceuticals industry changed in the last decade?

Digital is revolutionising pharmaceuticals

Globalisation of pharma

A decade of growth for pharma

Prescription medicines

The advent of precision medicine

Join us for another exciting decade in pharmaceuticals

Related Content

Sign up for post alerts

ICON & You The potential of together.

A better career. A better world. A better you.

ICON & You
The potential of together.